[1] Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neu-rologic, genetic and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol, 1968, 18(6): 603–618. <\p>
[2] 张如旭, 郭鹏, 任志军, 赵国华, 刘三妹, 刘婷, 资晓宏, 胡正茂, 夏昆, 唐北沙. LITAF、RAB7、LMNA和MTMR2基因在中国人腓骨肌萎缩症患者的突变分析. 遗传, 2010, 32(8): 817–823. <\p>
[3] Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA, McGuire AL, Zhang F, Stankiewicz P, Halperin JJ, Yang C, Gehman C, Guo D, Irikat RK, Tom W, Fantin NJ, Muzny DM, Gibbs RA. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med, 2010, 362(13): 1181–1191. <\p>
[4] Pareyson D, Scaioli V, Laurà M. Clinical and electrophy-siological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med, 2006, 8(1–2): 3–22. <\p>
[5] Banchs I, Casasnovas C, Albertí A, De Jorge L, Povedano M, Montero J, Martínez-Matos JA, Volpini V. Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol, 2009, 2009: 985415. <\p>
[6] Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain, 1980, 103(2): 259–280. <\p>
[7] Siskind CE, Panchal S, Smith CO, Feely SM, Dalton JC, Schindler AB, Krajewski KM. A review of genetic coun-seling for Charcot Marie Tooth Disease (CMT). J Genet Couns, 2013, 22(4): 422–436. <\p>
[8] Bird TD. Charcot-Marie-Tooth Neuropathy Type 2. Gene-Reviews, http://www.ncbi.nlm.nih.gov/books/NBK1285, 2013/09/03. <\p>
[9] 徐汪洋, 孙莲花, 顾鸣敏. 腓骨肌萎缩症的遗传特征及致病机制的研究进展. 国际遗传学杂志, 2010, 33(2): 93–96, 124. <\p>
[10] Patzkó Á, Shy ME. Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep, 2011, 11(1): 78–88. <\p>
[11] Züchner S, Vance JM. Molecular genetics of autosomal- dominant axonal Charcot-Marie-Tooth disease. Neuromo-lecular Med, 2006, 8(1–2): 63–74. <\p>
[12] 顾鸣敏, 王铸钢. 《医学遗传学》(第3版). 上海: 上海科学技术文献出版社, 2013, 75–80. <\p>
[13] 傅继梁主编, 王铸钢副主编. 基因工程小鼠. 上海: 上海科学技术出版社, 2006, 5–18. <\p>
[14] 吴乃虎, 张方, 黄美娟. 基因工程术语. 北京: 科学出版社, 2006, 193–194, 373. <\p>
[15] 张付峰. HSP22转基因小鼠模型的建立<\p>
[学位论文]. 长沙: 中南大学, 2008: 46–72. <\p>
[16] 胡以平, 曾溢滔. 后基因组时代的基因工程小鼠. 第二军医大学学报, 2003, 24(2): 117–119. <\p>
[17] Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell, 2001, 105(5): 587–597. <\p>
[18] Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M, Southwood C, Wu X, Gow A, Feltri ML, Wrabetz L, Shy ME. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain, 2012, 135(7): 2032–2047. <\p>
[19] Xu WY, Gu MM, Sun LH, Guo WT, Zhu HB, Ma JF, Yuan WT, Kuang Y, Ji BJ, Wu XL, Chen Y, Zhang HX, Sun FT, Huang W, Huang L, Chen SD, Wang ZG. A nonsense mutation in DHTKD1 causes Charcot-Marie- Tooth disease type 2 in a large Chinese pedigree. Am J Hum Genet, 2012, 91(6): 1088–1094. <\p>
[20] Tanaka Y, Hirokawa N. Mouse models of Charcot-Marie- Tooth disease. Trends Genet, 2002, 18(12): S39–S44. <\p>
[21] Detmer SA, Vande Velde C, Cleveland DW, Chan DC. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot- Marie-Tooth type 2A. Hum Mol Genet, 2008, 17(3): 367– 375. <\p>
[22] Guillet V, Gueguen N, Cartoni R, Chevrollier A, Desquiret V, Angebault C, Amati-Bonneau P, Procaccio V, Bonneau D, Martinou JC, Reynier P. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation. FASEB J, 2011, 25(5): 1618– 1627. <\p>
[23] De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, Szepetowski P, Hammadouche T, Vandenberghe A, Stewart CL, Grid D, Lévy N. Homozygous Defects in LMNA, encoding lamin A/C Nuclear-Envelope Proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth Disorder Type 2) and mouse. Am J Hum Genet, 2002, 70(3): 726– 736. <\p>
[24] Poitelon Y, Kozlov S, Devaux J, Vallat JM, Jamon M, Roubertoux P, Rabarimeriarijaona S, Baudot C, Hama-douche T, Stewart CL, Levy N, Delague V. Behavioral and molecular exploration of the AR-CMT2A mouse model Lmna (R298C/R298C). Neuromolecular Med, 2012, 14(1): 40–52. <\p>
[25] Seburn KL, Nangle LA, Cox GA, Schimmel P, Burgess RW. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron, 2006, 51(6): 715–726. <\p>
[26] Motley WW, Seburn KL, Nawaz MH, Miers KE, Cheng J, Antonellis A, Green ED, Talbot K, Yang XL, Fischbeck KH, Burgess RW. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild- type GARS levels. PLoS Genet, 2011, 7(12): e1002399. <\p>
[27] Seo AJ, Shin YH, Lee SJ, Kim D, Park BS, Kim S, Choi KH, Jeong NY, Park C, Jang JY, Huh Y, Jung J. A novel adenoviral vector-mediated mouse model of Charcot-Marie- Tooth type 2D (CMT2D). J Mol Histol, 2013, Epub ahead of print. <\p>
[28] Shen H, Barry DM, Dale JM, Garcia VB, Calcutt NA, Garcia ML. Muscle pathology without severe nerve patho¬logy in a new mouse model of Charcot-Marie-Tooth disease type 2E. Hum Mol Genet, 2011, 20(13): 2535–2548. <\p>
[29] Dale JM, Villalon E, Shannon SG, Barry DM, Markey RM, Garcia VB, Garcia ML. Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E. Genes Brain Behav, 2012, 11(3): 360–365. <\p>
[30] Filali M, Dequen F, Lalonde R, Julien JP. Sensorimotor and cognitive function of a NEFL(P22S) mutant model of Charcot-Marie-Tooth disease type 2E. Behav Brain Res, 2011, 219(2): 175–180. <\p>
[31] Dequen F, Filali M, Larivière RC, Perrot R, Hisanaga S, Julien JP. Reversal of neuropathy phenotypes in condi¬tional mouse model of Charcot-Marie-Tooth disease type 2E. Hum Mol Genet, 2010, 19(13): 2616–2629. <\p>
[32] d'Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, Vanden Berghe P, Timmerman V, Robberecht W, Van Den Bosch L. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1- induced Charcot-Marie-Tooth disease. Nat Med, 2011, 17(8): 968–974. <\p>
[33] Bogdanik LP, Sleigh JN, Tian C, Samuels ME, Bedard K, Seburn KL, Burgess RW. Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease. Dis Model Mech, 2013, 6(3): 780–792. <\p>
[34] 郭文婷. Dhtkd1基因点突变敲入小鼠模型的建立与表型初步分析<\p>
[学位论文]. 上海: 上海交通大学, 2013. <\p>
[35] Saito M, Hayashi Y, Suzuki T, Tanaka H, Hozumi I, Tsuji S. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology, 1997, 49(6): 1630–1635. <\p>
[36] Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schröder JM, Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet, 2004, 36(5): 449–451. <\p>
[37] Bouhouche A, Benomar A, Birouk N, Mularoni A, Meggouh F, Tassin J, Grid D, Vandenberghe A, Yahyaoui M, Chkili T, Brice A, LeGuern E. A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21. 2-q21. 3. Am J Hum Genet, 1999, 65(3): 722–727. <\p>
[38] Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol, 1999, 147(5): 913–920. <\p>
[39] Ismailov SM, Fedotov VP, Dadali EL, Polyakov AV, Van Broeckhoven C, Ivanov VI, De Jonghe P, Timmerman V, Evgrafov OV. A new locus for autosomal dominant Char-cot-Marie-Tooth disease type 2 (CMT2F) maps to chro-mosome 7q11-q21. Eur J Hum Genet, 2001, 9(8): 646– 650. <\p>
[40] 郭文婷, 徐汪洋, 顾鸣敏. 无义介导的mRNA降解机制及其在单基因遗传病中的作用. 遗传, 2012, 34(8): 935– 942. <\p>
[41] Weedon MN, Hastings R, Caswell R, Xie W, Paszkiewicz K, Antoniadi T, Williams M, King C, Greenhalgh L, Newbury-Ecob R, Ellard S. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet, 2011, 89(2): 308–312. <\p>
[42] Azzedine H, Senderek J, Rivolta C, Chrast R. Molecular genetics of charcot-marie-tooth disease: from genes to genomes. Mol Syndromol, 2012, 3(5): 204–214.<\p> |